Evidence map›Paper›PMID 39144230›Full record

ArticleFrontiers in microbiology2024

Bibliometric analysis of global research trends between gut microbiota and breast cancer: from 2013 to 2023.

Xianguang Deng, Hua Yang, Lingjia Tian, Jie Ling, Hui Ruan, Anqi Ge, Lifang Liu, Hongqiao Fan

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Mammary Gland Microbiota in Benign Breast Diseases.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xianguang DengDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Hua YangDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Lingjia TianDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Jie LingDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Hui RuanDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Anqi GeDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Lifang LiuDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Hongqiao FanDepartment of Cosmetic and Plastic Surgery, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer is the most prevalent cancer globally and is associated with significant mortality. Recent research has provided crucial insights into the role of gut microbiota in the onset and progression of breast cancer, confirming its impact on the disease's management. Despite numerous studies exploring this relationship, there is a lack of comprehensive bibliometric analyses to outline the field's current state and emerging trends. This study aims to fill that gap by analyzing key research directions and identifying emerging hotspots. Method: Publications from 2013 to 2023 were retrieved from the Web of Science Core Collection database. The VOSviewer, R language and SCImago Graphica software were utilized to analyze and visualize the volume of publications, countries/regions, institutions, authors, and keywords in this field. Results: A total of 515 publications were included in this study. The journal Conclusion: Research on the relationship between gut microbiota and breast cancer is expanding. Attention should be focused on understanding the mechanisms of their interaction, particularly the metabolite-microbiota-breast cancer crosstalk. These insights have the potential to advance prevention, diagnosis, and treatment strategies for breast cancer. This bibliometric study provides a comprehensive assessment of the current state and future trends of research in this field, offering valuable perspectives for future studies on gut microbiota and breast cancer.

Indexed as

bibliometricsbreast cancergut microbiotametabolomicsprobiotics

Identifiers

PMID39144230
PMCPMC11322113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.